Revenues reached $56.8 million during the quarter, up 8.0 percent over the same period in 2005. On a pro-forma basis, excluding the recently sold AlbaHealth business, first quarter revenues reached $49.4 million, up 11.0 percent over the same period in 2005.
Gross margins reached 24.5 percent and operating margins reached 14.1 percent in the quarter. On a pro-forma basis excluding AlbaHealth, gross margins reached 24.3 percent and operating margins reached 15.1 percent in the quarter.
Net income reached $5.4 million (9.5 percent of revenues). On a pro-forma basis excluding AlbaHealth, net income reached $5.2 million (10.6 percent of revenues).
Fully diluted EPS was $0.26 in the quarter compared with $0.07 in the same period in 2005. On a pro-forma basis excluding AlbaHealth, fully diluted EPS reached $0.25 in the quarter compared with $0.05 in the same period in 2005.
EBITDA for the quarter was $10.5 million compared with $5.6 million in the same period in 2005. On a pro-forma basis excluding AlbaHealth, EBITDA was $9.8 million in the quarter compared with $4.3 million in the same period in 2005.
Tefron has established itself as the epitome of fabric design, innovation and manufacturing. By leveraging our expertise of "designing to the body" in intimate apparel, Tefron has become the global leader in seamless and engineered apparel, and quickly taken a dominant market position in performance sports wear.